Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.

Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, Klosterkötter J, Hellmich M, Koethe D.

Transl Psychiatry. 2012 Mar 20;2:e94. doi: 10.1038/tp.2012.15.

2.

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis.

Koethe D, Giuffrida A, Schreiber D, Hellmich M, Schultze-Lutter F, Ruhrmann S, Klosterkötter J, Piomelli D, Leweke FM.

Br J Psychiatry. 2009 Apr;194(4):371-2. doi: 10.1192/bjp.bp.108.053843. Erratum in: Br J Psychiatry. 2011 Jun; 198(6):495.

3.

Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum.

Gebeh AK, Willets JM, Marczylo TH, Konje JC.

J Matern Fetal Neonatal Med. 2014 Jun;27(9):954-9. doi: 10.3109/14767058.2013.847413. Epub 2013 Oct 22.

PMID:
24117326
4.

Elevated anandamide and related N-acylethanolamine levels occur in the peripheral blood of women with ectopic pregnancy and are mirrored by changes in peripheral fatty acid amide hydrolase activity.

Gebeh AK, Willets JM, Bari M, Hirst RA, Marczylo TH, Taylor AH, Maccarrone M, Konje JC.

J Clin Endocrinol Metab. 2013 Mar;98(3):1226-34. doi: 10.1210/jc.2012-3390. Epub 2013 Jan 31.

PMID:
23372171
5.

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.

Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T.

Health Technol Assess. 2017 Sep;21(49):1-56. doi: 10.3310/hta21490.

6.

Clozapine with amisulpride for refractory schizophrenia.

Agelink MW, Kavuk I, Ak I.

Am J Psychiatry. 2004 May;161(5):924-5. No abstract available.

PMID:
15121665
7.
8.
9.

Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.

Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, Hillard CJ, Yehuda R.

Psychoneuroendocrinology. 2013 Dec;38(12):2952-61. doi: 10.1016/j.psyneuen.2013.08.004. Epub 2013 Sep 10.

10.

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.

Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkötter J, Piomelli D.

Neuropsychopharmacology. 2004 Nov;29(11):2108-14.

11.
12.

Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind study.

Lin CH, Wang FC, Lin SC, Huang YH, Chen CC, Lane HY.

Int Clin Psychopharmacol. 2013 Sep;28(5):267-74. doi: 10.1097/YIC.0b013e3283633a83.

PMID:
23778382
13.

Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.

Delcker A, Schoon ML, Oczkowski B, Gaertner HJ.

Pharmacopsychiatry. 1990 May;23(3):125-30.

PMID:
1973843
14.

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.

Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L, Neatby MA, Schneider M, Gerth CW, Hellmich M, Klosterkötter J, Piomelli D.

Schizophr Res. 2007 Aug;94(1-3):29-36. Epub 2007 Jun 13.

15.

Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group.

Peuskens J, Bech P, Möller HJ, Bale R, Fleurot O, Rein W.

Psychiatry Res. 1999 Nov 8;88(2):107-17.

PMID:
10622347
16.

Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?

Blin O.

Encephale. 2000 Oct;26 Spec No 1:7-11. Review. English, French.

PMID:
11294060
17.

Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.

Martins CJ, Genelhu V, Pimentel MM, Celoria BM, Mangia RF, Aveta T, Silvestri C, Di Marzo V, Francischetti EA.

PLoS One. 2015 Nov 11;10(11):e0142728. doi: 10.1371/journal.pone.0142728. eCollection 2015.

18.

Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis.

Crippa JA, Hallak JE, Abílio VC, de Lacerda AL, Zuardi AW.

CNS Neurol Disord Drug Targets. 2015;14(8):970-8. Review.

PMID:
26350340
19.

A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.

Martin S, Lĵo H, Peuskens J, Thirumalai S, Giudicelli A, Fleurot O, Rein W; SOLIANOL Study Group.

Curr Med Res Opin. 2002;18(6):355-62.

PMID:
12442883
20.

Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia.

Lecrubier Y, Azorin M, Bottai T, Dalery J, Garreau G, Lempérière T, Lisoprawski A, Petitjean F, Vanelle JM.

Neuropsychobiology. 2001;44(1):41-6. Review.

PMID:
11408792

Supplemental Content

Support Center